These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8564389)

  • 41. The biophysical effects of insulin-releasing agents on islet cells.
    Matthews EK; Dean PM
    Postgrad Med J; 1970 Dec; ():Suppl:21-3. PubMed ID: 5500512
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of calcium association constants and ionophoretic properties of some prostaglandins and ionophores.
    Carsten ME; Miller JD
    Arch Biochem Biophys; 1978 Jan; 185(1):282-3. PubMed ID: 341812
    [No Abstract]   [Full Text] [Related]  

  • 43. Experimental studies with glibenclamide in the rat.
    Alberti KG; Schein PS; Houghton CR; Williamson DH
    Postgrad Med J; 1970 Dec; ():Suppl:9-15. PubMed ID: 5500518
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcium transport by a beta-diketone in model membranes.
    Deleers M; Brasseur R; Malaisse WJ
    Chem Phys Lipids; 1983 Jul; 33(1):11-20. PubMed ID: 6627522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ionophoretic activity of meglitinide analogues.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):61-71. PubMed ID: 7671555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate. II. Ionophoretic and conformational aspects.
    Malaisse WJ; Nadi AB; Malaisse-Lagae F; Sato F; Lins L; Brasseur R
    Gen Pharmacol; 1995 Oct; 26(6):1319-25. PubMed ID: 7590126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nateglinide, a new agent for postprandial glucose control in type 2 diabetes.
    Kotapati S
    Conn Med; 2002 May; 66(5):269-72. PubMed ID: 12071108
    [No Abstract]   [Full Text] [Related]  

  • 49. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):339-47. PubMed ID: 8564389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Structures and mechanisms for non SU insulin secretagogues].
    Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.